4 Recruiting Studies Using Eculizumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Eculizumab
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
📍 Organizacion Medica de Investigacion (OMI) — Ciudad Autonoma Buenos Aires,
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
📍 The Oncology Institute of Hope & Innovation — Whittier, California
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors
📍 Carolinas Healthcare System — Charlotte, North Carolina
Paroxysmal Nocturnal Hemoglobinuria
View Study & Checklist ➔ NOT_YET_RECRUITING Phase4 💊 Investigational Drug / Biologic
Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD
📍 Massachusetts General Hospital — Boston, Massachusetts
NMOSD
View Study & Checklist ➔